Geller Advisors LLC Amgen Inc Transaction History

Geller Advisors LLC

$1.44 Billion
Q3 2024

A detailed history of Geller Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Geller Advisors LLC holds 1,851 shares of AMGN stock, worth $515,984. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,851

Previous 1,838 0.71%

Holding current value

$515,984

Previous $574,000 3.83%

% of portfolio

0.04%

Previous 0.04%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$309.38 - $337.38 $4,021 - $4,385	13 Added 0.71%	1,851 $596,000
Q2 2024 Aug 13, 2024	SELL	$262.75 - $319.31 $210,725 - $256,086	-802 Reduced 30.38%	1,838 $574,000
Q1 2024 May 14, 2024	BUY	$268.87 - $324.56 $12,099 - $14,605	45 Added 1.73%	2,640 $750,000
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $3,579 - $4,038	-14 Reduced 0.54%	2,595 $747,000
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $47,884 - $59,449	219 Added 9.16%	2,609 $701,000
Q2 2023 Aug 09, 2023	BUY	$214.27 - $253.37 $160,702 - $190,027	750 Added 45.73%	2,390 $530,000
Q1 2023 May 12, 2023	SELL	$225.79 - $275.2 $75,639 - $92,192	-335 Reduced 16.96%	1,640 $396,000
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $41,225 - $52,381	180 Added 10.03%	1,975 $518,000
Q3 2022 Nov 10, 2022	BUY	$224.46 - $253.15 $61,053 - $68,856	272 Added 17.86%	1,795 $405,000
Q2 2022 Aug 10, 2022	SELL	$230.71 - $256.74 $9,689 - $10,783	-42 Reduced 2.68%	1,523 $371,000
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $79,814 - $88,295	364 Added 30.31%	1,565 $378,000
Q4 2021 Feb 11, 2022	SELL	$198.88 - $227.6 $14,916 - $17,070	-75 Reduced 5.88%	1,201 $270,000
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $84,271 - $98,733	-397 Reduced 23.73%	1,276 $271,000
Q2 2021 Aug 09, 2021	SELL	$233.58 - $259.14 $700 - $777	-3 Reduced 0.18%	1,673 $408,000
Q1 2021 May 10, 2021	BUY	$221.91 - $258.6 $87,654 - $102,147	395 Added 30.84%	1,676 $417,000
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $3,754 - $4,175	16 Added 1.26%	1,281 $326,000
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $250,229 - $307,066	1,265 New	1,265 $298,000
Q4 2019 Feb 12, 2020	SELL	$189.21 - $243.2 $245,594 - $315,673	-1,298 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$174.11 - $208.62 $225,994 - $270,788	1,298 New	1,298 $251,000

Others Institutions Holding AMGN

# of Institutions

3,120

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geller Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geller Advisors LLC with notifications on news.

Account

Geller Advisors LLC Amgen Inc Transaction History